Prevalence and influence of cardiovascular kidney metabolic syndrome on outcomes after transcatheter aortic valve implantation

Key Points

• To investigate the prevalence and impact of cardiovascular kidney metabolic syndrome on patient outcomes after transcatheter aortic valve implantation.
• Analyzed patients undergoing transcatheter aortic valve implantation (TAVI)
• Assessed the prevalence of cardiovascular kidney metabolic syndrome (CKM)
• Evaluated associations between CKM burden and patient outcomes
• CKM was found to be highly prevalent in patients undergoing TAVI
• Increased CKM condition burden correlated with worse patient outcomes